Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GRNA

GreenLight Biosciences (GRNA) Stock Price, News & Analysis

GreenLight Biosciences logo

About GreenLight Biosciences Stock (NASDAQ:GRNA)

Advanced Chart

Key Stats

Today's Range
$0.30
$0.30
50-Day Range
$0.30
$0.30
52-Week Range
$0.18
$5.90
Volume
732 shs
Average Volume
486,986 shs
Market Capitalization
$45.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GRNA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GreenLight Biosciences and its competitors with MarketBeat's FREE daily newsletter.

GRNA Stock News Headlines

Greenlight Coupon Codes
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.
Greenlight Family Cash Card 2023 Review
See More Headlines

GRNA Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that GreenLight Biosciences investors own include Sangamo Therapeutics (SGMO), Anavex Life Sciences (AVXL), abrdn Asia-Pacific Income Fund (FAX), MSP Recovery (LIFW), Meta Platforms (META), NVIDIA (NVDA) and Blue Owl Capital (OBDC).

Company Calendar

Today
7/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:GRNA
CIK
1822691
Fax
N/A
Employees
280
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($1.14)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$167.05 million
Net Margins
-1,521.00%
Pretax Margin
-1,510.44%
Return on Equity
-374.26%
Return on Assets
-122.78%

Debt

Debt-to-Equity Ratio
0.49
Current Ratio
1.21
Quick Ratio
1.21

Sales & Book Value

Annual Sales
$10.20 million
Price / Sales
4.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.32 per share
Price / Book
0.94

Miscellaneous

Outstanding Shares
151,681,000
Free Float
105,722,000
Market Cap
$45.43 million
Optionable
Not Optionable
Beta
1.44
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:GRNA) was last updated on 7/21/2025 by MarketBeat.com Staff
From Our Partners